Methaq Hadi lafta | Biotechnology | Best Academic Researcher Award

Best Academic Researcher Award

Methaq Hadi Lafta
Iraqi Ministry of Education, Iraq
Methaq Hadi Lafta
Affiliation Iraqi Ministry of Education
Country Iraq
Scopus ID 57210173431
Documents 17
Citations 266
h-index 7
Subject Area Biotechnology
Event Applied Scientist Awards
ORCID 0000-0002-9978-6829

Methaq Hadi Lafta has contributed to the fields of biotechnology, molecular biology, immunology, bioinformatics, and environmental sciences through a combination of peer-reviewed publications, editorial responsibilities, and international research collaborations.[1] The Best Academic Researcher Award recognizes distinguished scholarly achievements, scientific productivity, and sustained contributions to interdisciplinary research and academic advancement. His academic profile reflects continued engagement in scientific publishing, reviewer activities, and biomedical research dissemination within regional and international scholarly communities.[2]

Abstract

Methaq Hadi Lafta is associated with multidisciplinary research activities involving biotechnology, molecular diagnostics, cancer biology, nanomaterials, genetics, and biomedical sciences. His scholarly record includes publications indexed in international databases and participation in editorial and reviewer roles across scientific journals. The research profile demonstrates an emphasis on translational biomedical research, computational biology applications, and healthcare-related scientific investigations.[3] The academic contributions and publication metrics support consideration for recognition within the framework of the Applied Scientist Awards.[4]

Keywords

Biotechnology, Molecular Biology, Immunology, Bioinformatics, Genetics, Cancer Research, Nanotechnology, Biomedical Sciences, Scientific Publishing, Academic Research

Introduction

Academic recognition awards are intended to acknowledge researchers whose work contributes to scientific advancement, interdisciplinary collaboration, and evidence-based innovation. In biotechnology and biomedical sciences, contemporary research increasingly integrates computational modeling, molecular analysis, and translational applications aimed at improving healthcare and scientific understanding.[3]

Research Profile

Methaq Hadi Lafta encompasses biotechnology, immunology, microbiology, molecular biology, environmental sciences, and bioinformatics. The profile includes publications addressing autoimmune diseases, cancer biology, nanomaterials, recurrent pregnancy loss, heavy metal toxicity, and computational drug design methodologies.[3]

Research Contributions

Methaq Hadi Lafta involve both experimental and theoretical scientific approaches. Several studies focus on biomedical applications of molecular and cellular biology, particularly within cancer pathways, immunological regulation, and extracellular vesicle technologies.[4]

  • Investigation of extracellular vesicles in autoimmune diseases and stem-cell-derived therapeutic systems.
  • Studies involving MXene-based nanomaterials for microbial toxin sensing and food safety applications.

Publications

Selected publications attributed to Methaq Hadi Lafta include peer-reviewed studies and interdisciplinary biomedical investigations indexed in scholarly databases.[1]

  1. The Developing Role of Extracellular Vesicles in Autoimmune Diseases: Special Attention to Mesenchymal Stem Cell-Derived Extracellular Vesicles.
  2. Designing Effective Multi-Target Drugs and Identifying Biomarkers in Recurrent Pregnancy Loss (RPL) Using In Vivo, In Vitro, and In Silico Approaches.

Research Impact

Methaq Hadi Lafta is reflected through publication metrics, citation counts, and interdisciplinary research visibility. According to indexed scholarly data, the profile includes 17 documents with 266 citations and an h-index of 7, indicating measurable scholarly engagement and citation activity within biomedical and biotechnology research areas.[1]

Award Suitability

Methaq Hadi Lafta demonstrates characteristics relevant to the Best Academic Researcher Award within the Applied Scientist Awards framework. The profile combines scientific publications, editorial contributions, interdisciplinary investigations, and participation in international academic networks.[4]

The researcher’s work in biotechnology and biomedical sciences aligns with contemporary scientific priorities involving translational medicine, molecular diagnostics, and innovative therapeutic approaches. Citation metrics, publication activity, and peer-review involvement collectively support suitability for academic recognition.

Conclusion

Methaq Hadi Lafta has established an interdisciplinary research profile spanning biotechnology, molecular medicine, bioinformatics, and biomedical sciences. The scholarly record includes peer-reviewed publications, editorial participation, and measurable research impact indicators. These academic contributions provide a basis for recognition within the Best Academic Researcher Award category associated with the Applied Scientist Awards.[2]

References

  1. Lafta, Methaq Hadi., Saif Adnan M. Advances in Engineering and Intelligence Systems (2022). Strategic Review: The CZTS Thin-Film Using Tandem and Multi-Junction Solar Cell.
    https://aeis.bilijipub.com/article_163968.html
  2. Hadi lafta, M., &  Markov, A. Cell Biology International (2021). P53 long noncoding RNA regulatory network in cancer development.
    https://onlinelibrary.wiley.com/doi/10.1002/cbin.11600
  3. Biomedicine & Pharmacotherapy. (2021). The developing role of extracellular vesicles in autoimmune diseases.
    https://www.sciencedirect.com/science/article/abs/pii/S1567576923008548
  4. Lafta, M.H., & Ahmadi, M. (2021). Mesenchymal stem cells and cancer therapy: insights into targeting the tumour vasculature.
    https://link.springer.com/article/10.1186/s12935-021-01836-9

Nisha Amarnath Jonniya | Biotechnology Awards | Women Researcher Award

Dr. Nisha Amarnath Jonniya | Biotechnology Awards | Women Researcher Award

Assistant Professor at National Institute of Technology Andhra Pradesh, India

Dr. Nisha Amarnath Jonniya is a dynamic and accomplished academician and researcher, currently serving as an Assistant Professor in the Department of Biotechnology at NIT Andhra Pradesh. With a profound expertise in computational biophysics and drug discovery, she has built a commendable research career focused on unraveling the conformational dynamics of biomolecules, particularly protein kinases implicated in various diseases. Dr. Jonniya obtained her Ph.D. from IIT Indore, where she investigated molecular modeling and simulation approaches for discovering inhibitors against hypertension-related kinases. Her professional journey spans prestigious institutions, including a current postdoctoral tenure at the University of California, San Diego under NIH funding. Her collaborative projects have addressed critical topics such as dengue virus inhibition and protein kinase regulation in Cushing’s syndrome. With over 30 high-impact publications and significant mentoring experience, Dr. Jonniya continues to contribute meaningfully to the fields of structural biology and computational drug design. Her dedication to translational research, coupled with active involvement in academic development programs and scientific outreach, underscores her commitment to both science and education.

Professional Profile

Education

Dr. Nisha Amarnath Jonniya’s academic journey exemplifies excellence and dedication. She completed her Ph.D. in Computational Biophysics from the Indian Institute of Technology (IIT) Indore, with a stellar CPI of 8.88. Her research, conducted under the guidance of Dr. Parimal Kar, focused on the conformational dynamics of kinases implicated in hypertension and involved molecular modeling and simulations to identify potent inhibitors. Prior to her doctoral studies, she earned an M.Tech in Bioinformatics from Maulana Azad National Institute of Technology (MANIT) Bhopal. Her M.Tech dissertation revolved around the application of support vector machine models for genotype classification in Hepatitis C Virus. Dr. Jonniya laid the foundation of her academic career with a B.Tech in Biotechnology from NIT Raipur, where she graduated with honors and departmental rank I. Her strong academic performance throughout her educational tenure, including top ranks at Kendriya Vidyalaya Kusmunda, reflects her consistent commitment to academic excellence and sets the groundwork for her future in high-impact research and teaching.

Professional Experience

Dr. Nisha Amarnath Jonniya’s professional experience spans prestigious institutions across India and the United States. Currently, she is serving as a Postdoctoral Employee at the University of California, San Diego (UCSD), where she is funded by the NIH to explore how disease-associated mutations affect the structure and function of Protein Kinase A. Under the mentorship of Prof. Susan Taylor, she is applying advanced computational techniques to elucidate allosteric regulations in kinases. Prior to this, Dr. Jonniya worked as a Research Associate at IIT Indore, focusing on antibody redesign and inhibitor identification against the dengue virus using in silico methods under a DST-funded project. She also served as a Lecturer at NIT Raipur from 2010 to 2015, where she taught undergraduate courses in biotechnology. Additionally, she held a teaching assistantship at IIT Indore during her Ph.D. studies. Her professional journey reflects a seamless integration of teaching, mentoring, and advanced research. Across these roles, she has contributed significantly to interdisciplinary biomedical research, mentored budding scientists, and fostered an academic environment conducive to collaborative innovation and scientific inquiry.

Research Interest

Dr. Nisha Amarnath Jonniya’s research interests lie at the intersection of structural biology, computational biophysics, and molecular drug design. Her work focuses on understanding the structural and thermodynamic properties of biomolecular systems, particularly proteins and glycans. She explores conformational dynamics using enhanced sampling molecular dynamics methods, providing insight into protein flexibility and function. A key emphasis of her research is on computational modeling of biomolecular recognition processes, including protein-protein and protein-ligand interactions, which are crucial for elucidating disease mechanisms and identifying therapeutic targets. Her projects have addressed critical biological problems, such as kinase regulation in hypertension and structural alterations in dengue virus proteins. Through structure-based drug discovery approaches, she has contributed to the identification of novel inhibitors and antibody enhancements. Dr. Jonniya’s ability to bridge theoretical modeling with translational biomedical applications underscores her long-term goal to contribute to precision medicine. Her research remains driven by the motivation to harness computational power for decoding complex biological phenomena and translating them into clinically relevant solutions.

Research Skills

Dr. Jonniya possesses a robust and versatile skill set in computational and bioinformatics tools essential for modern biomedical research. She is proficient in programming languages like Python, R, and shell scripting, and has advanced experience with molecular dynamics software such as AMBER and GROMACS. She routinely employs simulation and modeling tools like Schrodinger-Suite, Autodock, AlphaFold, UCSF Chimera, and PyMOL for structure-based drug design and protein analysis. Her skill set also includes visualization tools (VMD), plotting libraries (Matplotlib, Gnuplot), and LaTeX for scientific documentation. She has expertise in techniques such as sequence alignment, molecular docking, phylogenetic analysis, network analysis, virtual screening, and homology modeling. Dr. Jonniya is well-versed in both Windows and Linux operating systems, enhancing her adaptability across computational environments. Her command over enhanced sampling techniques, free energy calculations, and allosteric network mapping uniquely positions her for high-resolution insights into protein dynamics. These technical competencies, combined with a deep understanding of biomolecular interactions, empower her to lead impactful projects in structural biology and rational drug discovery.

Awards and Honors

Throughout her academic and professional career, Dr. Nisha Amarnath Jonniya has earned several notable accolades. She secured first rank in both her undergraduate (B.Tech in Biotechnology) and postgraduate (M.Tech in Bioinformatics) programs at NIT Raipur and MANIT Bhopal respectively, reflecting her exceptional academic abilities. She qualified the prestigious Graduate Aptitude Test in Engineering (GATE) in 2007 and was a consistent top performer from school through higher education. Dr. Jonniya received the Best Oral Presentation award at IIT Indore’s Symposium on Advances in Biosciences and Bioengineering in 2019. She has delivered invited talks and presented her research at renowned national and international platforms, including the Gordan Research Conference (USA) and Max Planck Institute (Germany). Her scientific contributions have been published in prestigious journals such as PNAS, eLife, and the Journal of Physical Chemistry B. In recognition of her expertise, she has served as a reviewer for reputed journals including ACS Omega and the Journal of Biomolecular Structure and Dynamics. These honors underscore her academic excellence, leadership in research, and ongoing contributions to the scientific community.

Conclusion

Dr. Nisha Amarnath Jonniya represents the epitome of dedication, innovation, and academic brilliance in the field of computational biology. Her multidisciplinary background, encompassing biotechnology, bioinformatics, and biophysics, has enabled her to address pressing biomedical challenges through in silico approaches. From top academic ranks to international collaborations and high-impact publications, her journey reflects a commitment to excellence and a passion for scientific inquiry. As an educator, she has not only taught and mentored students at premier institutions but also organized and participated in numerous scientific workshops and conferences, contributing to knowledge dissemination and capacity building. Her research continues to break new ground in understanding molecular mechanisms of diseases and designing targeted therapeutics. Moving forward, Dr. Jonniya is well-positioned to make transformative contributions to personalized medicine, drug development, and molecular therapeutics. Her career serves as a model for aspiring researchers aiming to blend computational skills with biological insight to tackle complex healthcare problems of the 21st century.

Publications Top Notes

  • Title: Current and novel therapeutic molecules and targets in Alzheimer’s disease
    Authors: A. Kumar, C.M. Nisha, C. Silakari, I. Sharma, K. Anusha, N. Gupta, P. Nair, …
    Year: 2016
    Citations: 191

  • Title: Molecular Docking and In Silico ADMET Study Reveals Acylguanidine 7a as a Potential Inhibitor of β‐Secretase
    Authors: C.M. Nisha, A. Kumar, P. Nair, N. Gupta, C. Silakari, T. Tripathi, A. Kumar
    Year: 2016
    Citations: 166

  • Title: Docking and ADMET prediction of few GSK-3 inhibitors divulges 6-bromoindirubin-3-oxime as a potential inhibitor
    Authors: C.M. Nisha, A. Kumar, A. Vimal, B.M. Bai, D. Pal, A. Kumar
    Year: 2016
    Citations: 119

  • Title: Elucidating biophysical basis of binding of inhibitors to SARS-CoV-2 main protease by using molecular dynamics simulations and free energy calculations
    Authors: M.F. Sk, R. Roy, N.A. Jonniya, S. Poddar, P. Kar
    Year: 2021
    Citations: 86

  • Title: Investigating phosphorylation-induced conformational changes in WNK1 kinase by molecular dynamics simulations
    Authors: N.A. Jonniya, M.F. Sk, P. Kar
    Year: 2019
    Citations: 51

  • Title: Computational investigation of structural dynamics of SARS-CoV-2 methyltransferase-stimulatory factor heterodimer nsp16/nsp10 bound to the cofactor SAM
    Authors: M.F. Sk, N.A. Jonniya, R. Roy, S. Poddar, P. Kar
    Year: 2020
    Citations: 44

  • Title: Identification of potential inhibitors against Epstein–Barr virus nuclear antigen 1 (EBNA1): An insight from docking and molecular dynamic simulations
    Authors: S. Jakhmola, N.A. Jonniya, M.F. Sk, A. Rani, P. Kar, H.C. Jha
    Year: 2021
    Citations: 40

  • Title: Immunoinformatics approach to design multi-epitope-subunit vaccine against bovine ephemeral fever disease
    Authors: S. Pyasi, V. Sharma, K. Dipti, N.A. Jonniya, D. Nayak
    Year: 2021
    Citations: 35*

  • Title: Investigating specificity of the anti-hypertensive inhibitor WNK463 against With-No-Lysine kinase family isoforms via multiscale simulations
    Authors: N.A. Jonniya, P. Kar
    Year: 2020
    Citations: 30

  • Title: Finding potent inhibitors against SARS-CoV-2 main protease through virtual screening, ADMET, and molecular dynamics simulation studies
    Authors: R. Roy, M.F. Sk, N.A. Jonniya, S. Poddar, P. Kar
    Year: 2022
    Citations: 23